Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

The role of medical debt in American bankruptcy

Medical debt is a significant factor in the reasons Americans file for bankruptcy, and Americans facing major health scares are also likely to face financial setbacks.

Thumbnail

Justice Department sues CVS subsidiary Omnicare

A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.

Thumbnail

HHS proposals aim to boost organ donation supply

HHS has issued a set of two proposed rules aimed at improving the availability of organs for the 113,000 Americans on waitlists for transplants.

Thumbnail

Humana acquiring hospice pharmacy Enclara Healthcare

Louisville-based Humana, the nation’s third-largest health insurance provider, is acquiring a large privately held hospice pharmacy and benefit management providers, Enclara Healthcare.

Thumbnail

Top 10 healthiest states in America

Vermont is ranked as the nation’s healthiest state, according to UnitedHealth Group, which released its annual population health rankings. Mississippi trails the country as the least healthy state in the nation.

Thumbnail

Digital health pharma deals reach new high in 2019

Seeking to accelerate technological capabilities, healthcare investors have been snapping up AI and machine learning companies and driving up digital health M&A in the pharmaceutical and biotechnology space as a result.

Thumbnail

FDA workshop to explore AI’s impact on imaging

AI’s impact on medical imaging continues to be one of the most significant trends of the last several years, and now the FDA has announced a public workshop focused on that very subject.

Thumbnail

Wyden, Booker share concerns about the use of AI in healthcare

U.S. Senators Ron Wyden and Cory Booker want to know what government agencies and insurance providers are doing to make sure health systems avoid the use of biased algorithms.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.